Demonstration of the abnormal conformational transition of amyloid proteins and it's application as an early diagnostic tool
Demonstration of the abnormal conformational transition of amyloid proteins and it's application as an early diagnostic tool
批准号:
21200072
负责人:
POPIEL HELENA Akiko
金额:
$22.44万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Innovative Areas (Research a proposed research project)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2012
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In the prion diseases, the abnormal structure of the disease-causing protein is transmitted to proteins with a normal structure. In this study, we aimed to elucidate whether the abnormal structure of the disease-causing proteins of the polyglutamine (polyQ) neurodegenerative diseases can also be transmitted, and whether this phenomenon could be used for detection of minute levels of abnormal polyQ proteins. We found that addition of a minute level of abnormal polyQ protein to normal polyQ proteins causes acceleration of the structural transition of the proteins. Furthermore, for detection of proteins with an abnormal structure, we analyzed systems involving both turbidity as well as fluorescence, and found that they both had equal sensitivity. We also determined a purification method of the polyQ protein that allows structural transition of the protein at high efficiency.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
ポリグルタミン病モデルマウスに対する凝集阻害ペプチドQBP1を用いた遺伝子治療
使用聚集抑制肽 QBP1 对多聚谷氨酰胺疾病模型小鼠进行基因治疗
DOI:
--
发表时间:
2009
期刊:
影响因子:
--
作者:
[ポピエル明子, 藤掛伸宏, 戸田達史, 村松慎一, 和田圭司, 永井義隆]
通讯作者:
永井義隆
AAV5を用いた分子シャペロンの遺伝子治療によるポリグルタミン病モデルマウスの封入体形成と神経症状の抑制効果
AAV5分子伴侣基因治疗对多聚谷氨酰胺疾病模型小鼠包涵体形成和神经症状的抑制作用
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[永井義隆, 他]
通讯作者:
他
17-AAG, an HSF1-activator, suppresses polyglutamine-induced neurodegeneration via induction of molecular chaperones
17-AAG 是一种 HSF1 激活剂,通过诱导分子伴侣抑制多聚谷氨酰胺诱导的神经变性
DOI:
--
发表时间:
2009
期刊:
影响因子:
--
作者:
[Nagai Y, Fujikake N, Popiel HA, Okamoto Y, Yamaguchi M, Toda T, Wada K]
通讯作者:
Wada K
DOI:
10.1007/s13311-013-0184-7
发表时间:
2013-03
期刊:
Neurotherapeutics
影响因子:
5.7
作者:
[H. A. Popiel;T. Takeuchi;James R. Burke;Warren J. Strittmatter;T. Toda;K. Wada;Y. Nagai]
通讯作者:
H. A. Popiel;T. Takeuchi;James R. Burke;Warren J. Strittmatter;T. Toda;K. Wada;Y. Nagai
Induction of molecular chaperones as a therapeutic strategy for the polyglutamine diseases
诱导分子伴侣作为多谷氨酰胺疾病的治疗策略
DOI:
--
发表时间:
2010
期刊:
Curr Pharm Biotechnol
影响因子:
--
作者:
[Nagai Y, Fujikake N, Popiel HA, Wada K]
通讯作者:
Wada K
共 14 条
Therapy for the polyglutamine diseases via selection of oligomer inhibitors using new technologies SPR & FCS
-
批准号:22790837
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.5万
-
财政年份:2010
-
负责人:POPIEL HELENA Akiko
-
依托单位: